Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. 310.299.1717 Office.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

AUGUST 30, 2019

Fairbanks became the first city in Alaska to adopt a resolution allowing the on-site consumption of cannabis. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis. billion by 2024. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

JUNE 30, 2019

The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction. billion in 2024, nearly triple the US$14.9 The panel also took up a bill sponsored by Rep. The 45-member Global Cannabis Partnership , which includes Canopy Growth Corp. and Hexo Corp.’s

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40